VMP 9553111000001105

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Ibandronic acid 150mg tablets
BNF code 0606020W0AAADAD
Virtual Therapeutic Moiety Ibandronic acid
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Ibandronic sodium monohydrate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 420936009
Strength value numerator 150.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Bonviva 150mg tablets (Atnahs Pharma UK Ltd)
Bonviva 150mg tablets (CST Pharma Ltd)
Bonviva 150mg tablets (Sigma Pharmaceuticals Plc)
Ibandronic acid 150mg tablets (A A H Pharmaceuticals Ltd)
Ibandronic acid 150mg tablets (Accord-UK Ltd)
Ibandronic acid 150mg tablets (Alliance Healthcare (Distribution) Ltd)
Ibandronic acid 150mg tablets (Aspire Pharma Ltd)
Ibandronic acid 150mg tablets (Consilient Health Ltd)
Ibandronic acid 150mg tablets (Crescent Pharma Ltd)
Ibandronic acid 150mg tablets (Medical Valley Invest AB)
Ibandronic acid 150mg tablets (Medihealth (Northern) Ltd)
Ibandronic acid 150mg tablets (Phoenix Healthcare Distribution Ltd)
Ibandronic acid 150mg tablets (Sandoz Ltd)
Ibandronic acid 150mg tablets (Sigma Pharmaceuticals Plc)
Ibandronic acid 150mg tablets (Viatris UK Healthcare Ltd)
Ibandronic acid 150mg tablets (Zentiva Pharma UK Ltd)
Virtual Medicinal Product Packs
Ibandronic acid 150mg tablets 1 tablet
Ibandronic acid 150mg tablets 3 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback